We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Keurig Dr Pepper
KDP
$42.3B
| $1.13M | ﹤0.01% |
40,190
-2,214,296
| -98% | -$60.8M |
|
|
PR
2077
Permian Resources
PR
$17.7B
| $1.12M | ﹤0.01% |
80,162
-1,750,001
| -96% | -$23.5M |
|
|
FCT
2078
DELISTED
First Trust Senior Floating Rate Income Fund II
FCT
| $1.12M | ﹤0.01% |
+111,622
| New | +$1.09M |
|
2079
PUT
Danaher
DHR
$143B
| $1.12M | ﹤0.01% |
4,900
+3,400
| +227% | +$747K |
|
2080
TransDigm Group
TDG
$68.9B
| $1.12M | ﹤0.01% |
843
+260
| +45% | +$341K |
|
2081
Autohome
ATHM
$2.6B
| $1.12M | ﹤0.01% |
+50,150
| New | +$1.25M |
|
2082
PUT
GE HealthCare
GEHC
$33.3B
| $1.12M | ﹤0.01% |
13,600
+6,100
| +81% | +$475K |
|
2083
TriNet
TNET
$3.22B
| $1.11M | ﹤0.01% |
18,824
+15,794
| +521% | +$938K |
|
|
EVMN
2084
Evommune Inc
EVMN
$511M
| $1.11M | ﹤0.01% |
+65,000
| New | +$1.22M |
|
2085
CRISPR Therapeutics
CRSP
$5.22B
| $1.11M | ﹤0.01% |
+21,202
| New | +$1.27M |
|
2086
PUT
Phillips 66
PSX
$92.8B
| $1.11M | ﹤0.01% |
+8,600
| New | +$1.16M |
|
2087
Northeast Bank
NBN
$1.16B
| $1.11M | ﹤0.01% |
10,673
+7,699
| +259% | +$718K |
|
2088
Ibotta
IBTA
$769M
| $1.11M | ﹤0.01% |
+48,775
| New | +$1.32M |
|
2089
Photronics
PLAB
$1.97B
| $1.11M | ﹤0.01% |
+34,634
| New | +$893K |
|
2090
CALL
BigBear.ai
BBAI
$1.6B
| $1.11M | ﹤0.01% |
+205,000
| New | +$1.34M |
|
2091
MannKind Corp
MNKD
$1.2B
| $1.11M | ﹤0.01% |
194,978
+82,462
| +73% | +$454K |
|
2092
Elicio Therapeutics
ELTX
$82.7M
| $1.1M | ﹤0.01% |
138,762
-9,314
| -6% | -$84.5K |
|
|
CMA
2093
CALL
DELISTED
Comerica
CMA
| $1.1M | ﹤0.01% |
12,700
-75,200
| -86% | -$6.05M |
|
2094
Blackbaud
BLKB
$2.1B
| $1.1M | ﹤0.01% |
17,388
+11,245
| +183% | +$696K |
|
2095
CALL
Workday
WDAY
$51B
| $1.1M | ﹤0.01% |
5,100
+3,300
| +183% | +$750K |
|
2096
Marathon Petroleum
MPC
$100B
| $1.09M | ﹤0.01% |
6,716
-68,865
| -91% | -$12.9M |
|
2097
BrightView Holdings
BV
$1.08B
| $1.09M | ﹤0.01% |
86,176
-69,911
| -45% | -$887K |
|
2098
Corbus Pharmaceuticals
CRBP
$195M
| $1.09M | ﹤0.01% |
133,311
+109,893
| +469% | +$1.36M |
|
2099
Perdoceo Education
PRDO
$1.99B
| $1.08M | ﹤0.01% |
36,969
+27,898
| +308% | +$882K |
|
2100
PUT
Domino's
DPZ
$11.6B
| $1.08M | ﹤0.01% |
2,600
-700
| -21% | -$292K |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.